Bioanalytical laboratories continue to push for more efficient drugs and long-acting formulations, which require lower limits of quantification. It is hoped that substitution, refinement and reduction policies will be used to reduce the use of animal models. The growth of the biopharmaceutical industry has also brought consideration of additional analytical issues, such as solvation and nonspecific binding.

• Low sample volume processing
• High sensitivity due to low elution volume
• High reproducibility
• Low analytical sample failure rate
• Easy to use
• High throughput processing

SOLAµ Yes The first micro-eluting product designed to meet the needs of bioanalysts in a durable, easy-to-use format.